Correction to : Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy
An amendment to this paper has been published and can be accessed via the original article.
| Errataetall: |
ErratumFor: Mol Cancer. 2019 Apr 10;18(1):85. - PMID 30971271 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:19 |
|---|---|
| Enthalten in: |
Molecular cancer - 19(2020), 1 vom: 20. Mai, Seite 93 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Xu, Ke [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 30.06.2020 published: Electronic ErratumFor: Mol Cancer. 2019 Apr 10;18(1):85. - PMID 30971271 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1186/s12943-020-01214-5 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM310168678 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM310168678 | ||
| 003 | DE-627 | ||
| 005 | 20231225135513.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s12943-020-01214-5 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1033.xml |
| 035 | |a (DE-627)NLM310168678 | ||
| 035 | |a (NLM)32434536 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Xu, Ke |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Correction to |b Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 30.06.2020 | ||
| 500 | |a published: Electronic | ||
| 500 | |a ErratumFor: Mol Cancer. 2019 Apr 10;18(1):85. - PMID 30971271 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a An amendment to this paper has been published and can be accessed via the original article | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Published Erratum | |
| 700 | 1 | |a Park, Dongkyoo |e verfasserin |4 aut | |
| 700 | 1 | |a Magis, Andrew T |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Jun |e verfasserin |4 aut | |
| 700 | 1 | |a Zhou, Wei |e verfasserin |4 aut | |
| 700 | 1 | |a Sica, Gabriel L |e verfasserin |4 aut | |
| 700 | 1 | |a Ramalingam, Suresh S |e verfasserin |4 aut | |
| 700 | 1 | |a Curran, Walter J |e verfasserin |4 aut | |
| 700 | 1 | |a Deng, Xingming |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Molecular cancer |d 2002 |g 19(2020), 1 vom: 20. Mai, Seite 93 |w (DE-627)NLM120915979 |x 1476-4598 |7 nnns |
| 773 | 1 | 8 | |g volume:19 |g year:2020 |g number:1 |g day:20 |g month:05 |g pages:93 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1186/s12943-020-01214-5 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 19 |j 2020 |e 1 |b 20 |c 05 |h 93 | ||